Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cybin Inc. Common Shares (NY:CYBN)

5.990 +0.240 (+4.17%)
Streaming Delayed Price Updated: 3:21 PM EST, Dec 10, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cybin Inc. Common Shares

< Previous 1 2
...
17 18 19 20 21 22 23 24 25
...
41 42 Next >
News headline image
Psychedelic Stock Gainers And Losers From October 12, 2022 ↗
GAINERS: Allied (OTC:ALID) shares closed up 48.05% at $0.48 
Via Benzinga
News headline image
Numinus Wellness, Small Pharma Among Top Psychedelic Movers Of Today ↗
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 7.61% at $0.12 
Via Benzinga
TinyGemsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN), The Chopra Foundation Note World Mental Health Day
Via Investor Brand Network
News headline image
Psychedelic Drugs Prove Their Worth In Clinical Trials
Novel psychedelic drugs have continuously proven their worth in clinical trials. Just recently, one company revealed that it was in the process of finalizing its Phase 1 first-in-human clinical trial... 
Via PressReach
News headline image
Psychedelic Stock Gainers And Losers From October 10, 2022 ↗
GAINERS: Cybin (AMEX:CYBN) shares closed up 5.51% at $0.63 LOSERS: 
Via Benzinga
News headline image
Cybin & The Chopra Foundation Recognize World Mental Health Day
From Cybin Inc.
Via Business Wire
News headline image
Psychedelic Drug Stocks Index Up Slightly This Week ↗
There are 8 stocks in the munKNEE Psychedelic Drug Stocks Index and this article reveals how its constituents performed this week, in descending order, since the end of August and YTD. 
Via Talk Markets
Study Finds Using Social Media May Negatively Affect Youths’ Mental Health
Via Investor Brand Network
News headline image
Psychedelic Stock Gainers And Losers From October 6, 2022 ↗
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 45.41% at $0.22 
Via Benzinga
PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) ‘Focused on Adding Targeted IP’
Via Investor Brand Network
Topics Intellectual Property
News headline image
Cybin Provides Update on its Intellectual Property Portfolio
From Cybin Inc.
Via Business Wire
News headline image
Colorado to Vote on Legalizing Psychoactives in November
Voters in Colorado will have a say in the legalization of psychedelic drugs this November as an initiative to legalize psilocybin mushrooms and other naturally occurring psychedelics appears on the... 
Via PressReach
Topics Supply Chain
News headline image
Allied, GH Research Among Top Psychedelic Movers Of Today ↗
GAINERS: Allied (OTC:ALID) shares closed up 31.58% at $0.60 
Via Benzinga
News headline image
Cybin, GH Research Among Top Psychedelic Movers Of Today ↗
GAINERS: Cybin (AMEX:CYBN) shares closed up 20.50% at $0.58 
Via Benzinga
News headline image
September Cannabis Category Performances Ranged From -6.3% To -39.0% ↗
The performances of the 5 cannabis categories ranged from -6.3% to -39.0% in September, and are now -13.6% to -67.0%, YTD, depending on the category. The S&P 500, in comparison, was -8.6% in September... 
Via Talk Markets
News headline image
Allied, Revive Therapeutics Among Top Psychedelic Movers Of Today ↗
GAINERS: Cybin (AMEX:CYBN) shares closed up 2.08% at $0.49 
Via Benzinga
News headline image
Allied, Compass Pathways Among Top Psychedelic Movers Of Today ↗
GAINERS: Mind Medicine (NASDAQ:MNMD) shares closed up 6.17% at $3.44 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From September 28, 2022 ↗
GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 10.48% at $1.16 
Via Benzinga
News headline image
Biomind Labs, Allied Among Top Psychedelic Movers Of Today ↗
GAINERS: Biomind Labs (OTC:BMNDF) shares closed up 11.10% at $1.10 
Via Benzinga
PsychedelicNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Enters Agreement to Obtain Novel Catalog of Psychedelic-Based Compounds
Via Investor Brand Network
Topics Intellectual Property
News headline image
Cybin Acquires Exclusive License To Mindset Pharma's Tryptamine Compounds Family ↗
Through its wholly-owned subsidiary, Cybin IRL Limited, Canadian-based psychedelics biotech Cybin Inc. (NYSE AMERICAN: CYBN) signed an agreement with next-gen psychedelics producer Mindset Pharma Inc. 
Via Benzinga
News headline image
Cybin Obtains Exclusive License to a Novel Catalog of Psychedelic-Based Compounds
From Cybin Inc.
Via Business Wire
News headline image
Small Pharma, Revive Therapeutics Among Top Psychedelic Movers Of Today ↗
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 9.91% at $0.13 
Via Benzinga
News headline image
The 5 Cannabis Categories Fell Even Further Last Week ↗
The 5 categories in the cannabis sector performed quite differently from each other again last week. The ones that lost least are the most peripheral to the growing and/or distribution of cannabis. 
Via Talk Markets
News headline image
Psychedelic Stocks Continue To Plummet: -16% This Week; -33% MTD; Now -57% YTD ↗
Look at how the only psychedelic stocks with market caps larger than $50M gave performed this last week. 
Via Talk Markets
News headline image
Psychedelic Stock Gainers And Losers From September 22, 2022 ↗
GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 2.80% at $1.10 
Via Benzinga
News headline image
Atlanta Becomes Latest City to Consider Decriminalizing Psychedelics
Atlanta just became the latest city to consider decriminalizing psychedelics. On September 12, just one week after San Francisco officially decriminalized psychedelics, a meeting was held by the City... 
Via PressReach
Atlanta Becomes Latest City to Consider Decriminalizing Psychedelics
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – September 22, 2022 – Atlanta just became the latest city to consider decriminalizing psychedelics. On September 12, just one... 
Via FinancialNewsMedia
News headline image
Psychedelic Stock Gainers And Losers From September 21, 2022 ↗
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 7.87% at $0.32 
Via Benzinga
BioMedNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Announces Participation in Upcoming Scientific and Investor Conferences
Via Investor Brand Network
< Previous 1 2
...
17 18 19 20 21 22 23 24 25
...
41 42 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.